Therapy Insight: diabetes and drug-eluting stents
Victor Legrand
Correspondence Service de Cardiologie, CHU de Liège Sart-Tilman, 4000 Liège, Belgium
Email vlegrand@chu.ulg.ac.be
Individuals with diabetes mellitus have worse outcomes, and particularly a higher rate of restenosis, following revascularization than those without diabetes. The advent of drug-eluting stents has, however, reignited enthusiasm for percutaneous coronary intervention in individuals with diabetes. In this Review, Victor Legrand evaluates drug-eluting stents as an alternative revascularization strategy to surgery in diabetic patients.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
